| 763748 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-003134 |
Kawashima Shusuke, Inozume Takashi, Kawazu Masahito, Ueno Toshihide, Nagasaki Joji, Tanji Etsuko, Honobe Akiko, Ohnuma Takehiro, Kawamura Tatsuyoshi, Umeda Yoshiyasu, Nakamura Yasuhiro, Kawasaki Tomonori, Kiniwa Yukiko, Yamasaki Osamu, Fukushima Satoshi, Ikehara Yuzuru, Mano Hiroyuki, Suzuki Yutaka, Nishikawa Hiroyoshi, Matsue Hiroyuki, Togashi Yosuke |
| 763747 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer |
2021-11-01 |
10.1136/jitc-2021-003609 |
Sprooten Jenny, Vankerckhoven Ann, Vanmeerbeek Isaure, Borras Daniel M, Berckmans Yani, Wouters Roxanne, Laureano Raquel S, Baert Thais, Boon Louis, Landolfo Chiara, Testa Antonia Carla, Fischerova Daniela, Van Holsbeke Caroline, Bourne Tom, Chiappa Valentina, Froyman Wouter, Schols Dominique, Agostinis Patrizia, Timmerman Dirk, Tejpar Sabine, Vergote Ignace, Coosemans An, Garg Abhishek D |
| 763746 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors |
2021-11-01 |
10.1136/jitc-2021-003388 |
Conlon Kevin, Watson Dionysios C, Waldmann Thomas A, Valentin Antonio, Bergamaschi Cristina, Felber Barbara K, Peer Cody J, Figg William D, Potter E Lake, Roederer Mario, McNeel Douglas G, Thompson John A, Gupta Sumati, Leidner Rom, Wang-Gillam Andrea, Parikh Nehal S, Long Debby, Kurtulus Sema, Ho Lee Lang, Chowdhury Niladri Roy, Bender Florent, Pavlakis George N |
| 763745 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants |
2021-11-01 |
10.1136/jitc-2021-003351 |
Conde Enrique, Vercher Enric, Soria-Castellano Marta, Suarez-Olmos Jesús, Mancheño Uxua, Elizalde Edurne, Rodriguez M Luis, Glez-Vaz Javier, Casares Noelia, Rodríguez-García Estefanía, Hommel Mirja, González-Aseguinolaza Gloria, Uranga-Murillo Iratxe, Pardo Julian, Alkorta Gorka, Melero Ignacio, Lasarte Juan, Hervas-Stubbs Sandra |
| 763744 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study |
2021-11-01 |
10.1136/jitc-2021-002996 |
Lonardi Sara, Prete Alessandra Anna, Morano Federica, Messina Marco, Formica Vincenzo, Corsi Domenico Cristiano, Orciuolo Corrado, Frassineti Giovanni Luca, Zampino Maria Giulia, Casagrande Mariaelena, Masi Gianluca, Ronzoni Monica, Scartozzi Mario, Buonadonna Angela, Mosconi Stefania, Ratti Margherita, Sartore-Bianchi Andrea, Tamburini Emiliano, Prisciandaro Michele, Bergamo Francesca, Spada Massimiliano, Corallo Salvatore, Vettore Valentina, Loupakis Fotios, Fassan Matteo, Del Bianco Paola, Zagonel Vittorina, Pietrantonio Filippo |
| 763743 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer |
2021-11-01 |
10.1136/jitc-2021-003237 |
Nalawade Saisha A, Shafer Paul, Bajgain Pradip, McKenna Mary K, Ali Arushana, Kelly Lauren, Joubert Jarrett, Gottschalk Stephen, Watanabe Norihiro, Leen Ann, Parihar Robin, Vera Valdes Juan Fernando, Hoyos Valentina |
| 763742 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds |
2021-11-01 |
10.1136/jitc-2021-003850 |
van Diest Eline, Hernández López Patricia, Meringa Angelo D, Vyborova Anna, Karaiskaki Froso, Heijhuurs Sabine, Gumathi Bormin Jan, van Dooremalen Sanne, Nicolasen Mara J T, Gatti Lucrezia C D E, Johanna Inez, Straetemans Trudy, Sebestyén Zsolt, Beringer Dennis X, Kuball Jürgen |
| 763741 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy |
2021-11-01 |
10.1136/jitc-2021-002614 |
Munoz Luis Enrique, Huang Lei, Bommireddy Ramireddy, Sharma Richa, Monterroza Lenore, Guin Rohini N., Samaranayake Sarah G., Pack Christopher D., Ramachandiran Sampath, Reddy Shaker J.C., Shanmugam Mala, Selvaraj Periasamy |
| 763740 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response |
2021-11-01 |
10.1136/jitc-2021-003550 |
Kelly Andrew D, Murugesan Karthikeyan, Kuang Zheng, Montesion Meagan, Ross Jeffrey S, Albacker Lee A, Huang Richard S P, Lin Douglas I, Demirci Umut, Creeden James |
| 763739 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Activated but impaired IFN-γ production of mucosal-associated invariant T cells in patients with hepatocellular carcinoma |
2021-11-01 |
10.1136/jitc-2021-003685 |
Huang Wenyong, Ye Dongmei, He Wenjing, He Xiaoshun, Shi Xiaomin, Gao Yifang |
